2024-03-28T14:25:06Zhttp://repisalud.isciii.es/oai/requestoai:repisalud.isciii.es:20.500.12105/77232023-10-16T11:59:29Zcom_20.500.12105_15322com_20.500.12105_2051com_20.500.12105_2060com_20.500.12105_2052col_20.500.12105_16968col_20.500.12105_2061
00925njm 22002777a 4500
dc
Castilla Catalán, Jesús
author
Navascués, Ana
author
Casado, Itziar
author
Díaz-González, Jorge
author
Pérez-García, Alejandra
author
Fernandino, Leticia
author
Martínez-Baz, Iván
author
Aguinaga, Aitziber
author
Pozo Sanchez, Francisco
author
Ezpeleta, Carmen
author
2017-02
The 2016/17 mid-season vaccine effectiveness estimate against influenza A(H3N2) was 15% (95% confidence interval: -11 to 35) in Navarre. Comparing to individuals unvaccinated in the current and four prior seasons, effectiveness was 24% for current and 3-4 prior doses, 61% for current and 1-2 prior doses, 42% for only current vaccination, and 58% for 3-4 prior doses. This suggests moderate effectiveness for different combinations of vaccination in the current and prior seasons.
Euro Surveill. 2017 Feb;22(7).
1025-496X
http://hdl.handle.net/20.500.12105/7723
28230523
10.2807/1560-7917.ES.2017.22.7.30465
1560-7917
Eurosurveillance
Case control study
Influenza
Influenza vaccine
Influenza-like illness
Repeated vaccination
Vaccine effectiveness
Combined effectiveness of prior and current season influenza vaccination in northern Spain: 2016/17 mid-season analysis